TITLE:
Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy

CONDITION:
Mitochondrial Myopathy

INTERVENTION:
thioctic acid

SUMMARY:

      OBJECTIVES:

      I. Assess the efficacy of thioctic acid in treating a single patient with mitochondrial
      myopathy.
    

DETAILED DESCRIPTION:

      PROTOCOL OUTLINE: The patient receives one thioctic acid tablet 3 times a day. If patient
      experiences no side effects after 1 week, 2 tablets are administered and given 3 times a day
      over 3 months for compassionate use.

      The patient is followed at weeks 3, 8, and 12.
    

ELIGIBILITY:
Gender: Male
Age: N/A to N/A
Criteria:

        PROTOCOL ENTRY CRITERIA:

        --Disease Characteristics--

          -  Long standing ophthalmoparesis and fatiguable weakness of the limbs

          -  Mild ataxia and no central nervous system involvement

          -  History of mitochondrial DNA deletion and a measurable biochemical defect of the
             respiratory chain

          -  Steady deterioration in skeletal muscle mass and power over 5 years

        --Prior/Concurrent Therapy--

          -  Previous participation in studies of muscle disease natural history (CRC Protocol
             183A)
      
